Prognostic value of clonal chromosomal abnormalities in patients with primary myelodysplastic syndromes

American Journal of Hematology

Volumn 28, Issue 1, 1988, Pages 13-20

  Gyger, Martin ^a   Infante‐Rivard, Claire ^a   D'Angelo, Giovanni ^a   Forest, Lorraine ^a   Lussier, Pauline ^a  

^a MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

acute nonlymphocytic leukemia; bone marrow failure; cytogenetic; karyotype

Indexed keywords

ACUTE NONLYMPHOCYTIC LEUKEMIA; APLASTIC ANEMIA; CYTOGENETICS; HUMAN; KARYOTYPE; MAJOR CLINICAL STUDY; MYELODYSPLASTIC SYNDROME; PROGNOSIS;

ADULT; AGED; ANEMIA, REFRACTORY, WITH EXCESS OF BLASTS; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; CLONE CELLS; FEMALE; HUMAN; KARYOTYPING; MALE; MIDDLE AGE; MYELODYSPLASTIC SYNDROMES; PROGNOSIS;

EID: 0023912924     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.2830280104     Document Type: Article

References (35)

1. Prognosis of acute myeloblastic leukemia: Chromosomal correlation
2. Prognostic value of age and bone marrow karyotype in 78 adults with acute myelogenous leukemia
3. Prognostic importance of chromosome number in 136 untreated children with acute lymphoblastic leukemia
4. Chromosomal abnormalities identify high‐risk and low‐risk patients with acute lymphoblastic leukemia
5. Acute myelomonocytic leukemia with abnormal eosinophils and inv(16) or t(16:16) has a favorable prognosis
6. Correlation of morphology and karyotype
7. The French‐American‐British (FAB) Cooperative Group: Proposals for the classification of the myelodysplastic syndromes
8. Classification of the myelodysplastic syndromes
9. Myelodysplastic syndromes: Natural history and features of prognostic importance
10. Clinical significance of the new proposals for the classification of the myelodysplastic syndromes
11. Dysmyelopoietic syndromes. A search of prognostic factors in 193 patients
12. Myelodysplastic syndromes: A scoring system with prognostic significance
13. Natural course of myelodysplastic syndromes‐Helsinki experience
14. Modifications in the classifications of primary myelodysplastic syndromes: The addition of a scoring system
15. Regression models and life tables (with discussion)
16. Acute nodymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome secondary to treatment of other malignant diseases. Clinical and cytogenetic characteristics and results of in vitro culture of bone marrow and HLA typing
17. Nonrandom chromosome abnormalities in acute leukemia and dysmyelopoietic syndromes in patients with previously treated malignant disease
18. Interstitial deletion of the long arm of chromosome 5 (5q–) in leukemia and other hematological disorders: Clinical and biological relevance of variable breakpoint patterns
19. An international system for human cytogenetics nomenclature
20. Chromosomal banding patterns in acute leukemia
21. Nonparametric estimation from incomplete observations
22. High resolution banding analysis of the reciprocal translocation t(6;9) in acute nodymphocytic leukemia
23. Phase 1 clinical trial of 13‐cis‐retinoic acid in myelodysplastic syndromes
24. Refractory anemia with excess of blast cells : Prognostic factors and effect of treatment with androgens or cytosine arabinoside
25. The role of aggressive chemotherapy in the treatment of the myelodysplastic syndromes
26. Low dose cytosine arabinoside (Ara C) in myelodysplastic syndromes
27. Treatment of preleukemic syndromes with marrow transplantation
28. Bone marrow histology in myelodysplastic syndromes: II: Prognostic value of abnormal localization of immature precursors in MDS
29. Cytogenetic study of 88 cases of refractory anemia
30. Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes
31. Refined chromosome analysis as an independent prognostic indicator in de novo myelodysplastic syndromes
32. Preleukaemia: A long‐term prospective study of 326 patients
33. The prognostic value of chromosome studies in patients with the preleukemic syndrome (hemopoietic dysplasia)
34. Correlation between chromosomal abnormalities and a scoring system of dysmyelopoiesis in the myelodysplastic syndrome (MDS)
35. Multiple chromosomally distinct cell populations in myelodysplastic syndromes and their possible significance in the evolution of the disease